Hematology/Oncology News

ORLANDO — In this video from the AIMed24 Annual Meeting, Marissa Fayer discusses the use of novel AI imaging technology to assist radiologists in detecting breast cancer and cutting costs.

Researchers found various trends in melanoma incidence among young patients, one of which is that rates are steadily decreasing, according to a study.

Monique A. Hartley-Brown, MD, MMSc, turns life challenges into the desire and initiative to “change things for the better.”

Greater adherence to American dietary guideline recommendations appeared linked with reduced likelihood of prostate cancer progression among men undergoing active surveillance, study results showed.

Routine screening for financial toxicity during active cancer treatment is feasible, according to study results presented at ASCO Quality Care Symposium.

Health care practices that used telehealth services more frequently had a lower propensity to engage in some low-value services, results from a cohort study published in JAMA Network Open showed.

CHICAGO — Treatment with the heart failure medication sacubitril/valsartan was associated with a lower risk for chemotherapy-related heart damage among high-risk patients with cancer, according to preliminary results of the SARAH trial.

The FDA approved revumenib for the treatment of certain patients with advanced acute leukemia.

Clonal hematopoiesis did not occur significantly more often among patients who received hematopoietic stem cell transplantation than their donors, according to findings of a correlative laboratory study.

In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, highlights current challenges within the EGFR-mutated lung cancer space.